References
Grom AA, Mellins ED (2010) Macrophage activation syndrome: advances towards understanding pathogenesis. Curr Opin Rheumatol 22(5):561–566
Davy S, Consolaro A, Guseinova D, et al (2011) An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 38(4):764–768. (Epub 2011 Feb 1)
Cortis E, Insalaco A (2006) Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr Suppl 95(452):38–41
Khanna D, McMahon M, Furst DE (2004) Safety of tumour necrosis factor-alpha antagonists. Drug Saf 27(5):307–324
Flendrie M, Vissers W, Creemers M, et al (2005) Dermatological conditions during TNF-α-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 7(3):R666–R676
Clark P, Davidson D, Mervyn Letts M, Lawton L, Jawadi A (2003) Necrotizing fasciitis secondary to chickenpox infection in children. Can J Surg 46:9–14
Smyth A, Houlihan DD, Tuite H, Fleming C, O’Gorman TA (2010) Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report. J Med Case Rep 4:367
Choi K-H, Yoo W-H (2009) Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis. Rheumatol Int 29:463–466
Chan ATY, Cleeve V, Daymond TJ (2002) Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis. Postgrad Med J 78:47–48
Baghai M, Osmon DR, Wolk DM, Wold LE, Haidukewych GJ, Matteson EL (2001) Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept. Mayo Clin Proc 76(6):653–656
Hsieh T, Samson LM, Jabbour M, Os-mond M (2000) Necrotizing fasciitis in children in eastern Ontario: a case-control study. CMAJ 163(4):393–396
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buonuomo, P.S., Campana, A., Insalaco, A. et al. Necrotizing fasciitis in a pediatric patient treated with etanercept and cyclosporine for macrophage activation syndrome. Rheumatol Int 33, 1097–1098 (2013). https://doi.org/10.1007/s00296-011-2319-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-2319-7